Electrogastrography as potential diagnostic test in patients with gastric ischemia

Electrogastrography as potential diagnostic test in patients with gastric ischemia - Electrogastrography as diagnostic test in patients with gastric ischemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39396

Enrollment

Registered

2012-08-06

Start date

2012-11-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Splanchnic Syndrome (CSS) enduring blood shortage to abdominal organs

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy subjects: above 18 years of age. Normal abdominal arteries (no chronic splanchnic syndrome, CSS) verified using abdominal duplex ultrasound. Able to sit or lay down for 150 minutes.;Subjects with splanchnic ischemia: above 18 years of age. Proven chronic splanchnic syndrome, with abnormal tonometry. Able to sit or lay down for 150 minutes.

Exclusion criteria

Exclusion criteria: Healthy subjects should not suffer from symptoms or disease based on the gastrointestinal tract. No disease concerning cardiatric, pulmonary or internal medicine area's. Pregnant women. Wheelchair bound. Subjects with splanchnic ischemia: pregnant women. wheelchair bound. Presence of gastroparesis

Design outcomes

Secondary

Measure	Time frame
1) Determine whether a difference in HR-EGG is detectable between single and multiple CSS patients. We expect the latter to have much larger abnormalities than the first 2) Determine whether HR-EGG differences are seen in the healthy volunteer group when measured on different days (reproducibility) 3) Determine to what extent the under 2 noted differences could influence the primary study outcome 4) Determine to what extent the basic rhythm and/or propulsion speed in the HR-EGG normalizes in post intervention patients. 5) Determine to what extent EGG differs in people suffering from abdominal ischemia and patients suffering from both abdominal ischemia and diabetes mellitus.	—

Measure

Time frame

1) Determine whether a difference in HR-EGG is detectable between single and multiple CSS patients. We expect the latter to have much larger abnormalities than the first 2) Determine whether HR-EGG differences are seen in the healthy volunteer group when measured on different days (reproducibility) 3) Determine to what extent the under 2 noted differences could influence the primary study outcome 4) Determine to what extent the basic rhythm and/or propulsion speed in the HR-EGG normalizes in post intervention patients. 5) Determine to what extent EGG differs in people suffering from abdominal ischemia and patients suffering from both abdominal ischemia and diabetes mellitus.

—

Primary

Measure	Time frame
To determine whether patients with gastric ischemia have different EGG signals after a meal in comparison to healthy controls. Specifically we will be examining changes in basic rhythm (ECA) and propulsion speed between the different groups in a fasting state and after a test meal.	—

Countries

Netherlands

Outcome results